Cross-national disparities in drug interaction reporting and assessment between Switzerland and Austria: A retrospective, registry-based study using pharmacovigilance data
Drug–drug interactions (DDIs) are a significant contributor to adverse drug reactions (ADRs) in clinical practice. Despite established pharmacovigilance systems, underreporting and inconsistent causality assessment remain challenges. Switzerland and Austria offer a unique comparative setting due to similar healthcare i...